Sandoz Inc. v. Amgen Inc.

Supreme Court of the United States
Sandoz Inc. v. Amgen Inc., 137 S. Ct. 908 (2017)
197 L. Ed. 2d 82; 85 U.S.L.W. 3362; 2017 WL 125661; 2017 U.S. LEXIS 908

Sandoz Inc. v. Amgen Inc.

Opinion of the Court

The following briefing schedule is adopted:

Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioner in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioner in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017.

Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioner in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brief should bear a dark green cover. An amicus curiae may file only a single brief in this case.

Reference

Full Case Name
SANDOZ INC. v. AMGEN INC.
Status
Published